Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic ModelingJacqueline G. Gerhart, Robert H. Lurie, Fernando Carreño et al.|Clinical Pharmacokinetics|2021Cited by 39
Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term InfantsSamit Ganguly, Andrea N. Edginton, Jacqueline G. Gerhart et al.|Clinical Pharmacokinetics|2021Cited by 33
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric PopulationPatricia D. Maglalang, Lauri Filar, Jaydeep Sinha et al.|Clinical Pharmacokinetics|2024Cited by 5
CYP2D6-Guided Opioid Management and Postoperative Pain ControlLarisa H. Cavallari, Ruth C. Lehan, Erica N. Elwood et al.|JAMA Network Open|2026Cited by 4
Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with ObesityJaydeep Sinha, Sasidharan Taravath, Kanecia O. Zimmerman et al.|Clinical Pharmacokinetics|2025Cited by 0